Addex Therapeutics Ltd (ADXN) — Capital Reinvestment Ratio
Latest as of December 2020:
0.07x
Addex Therapeutics Ltd (ADXN) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow (CHF704.85K) in capital expenditures (CHF48.09K). See Addex Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
CHF704.85K
CHF
Capital Expenditures
CHF48.09K
CHF
Data as of
Dec 2020
Most recent filing
Addex Therapeutics Ltd Capital Reinvestment Ratio (2018–2018)
This chart tracks Addex Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Addex Therapeutics Ltd (2018–2018)
Year-by-year Capital Reinvestment Ratio for Addex Therapeutics Ltd from 2018 to 2018. For live market cap and broader valuation context, see ADXN market cap.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.01x | CHF1.75 Million | CHF9.05K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow